Trademark Overview
On Wednesday, March 26, 2025, a trademark application was filed for U-MCE with the United States Patent and Trademark Office. The USPTO has given the U-MCE trademark a serial number of 99104766. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, March 26, 2025. This trademark is owned by LTZ Therapeutics Inc.. The U-MCE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Diagnostic preparations for medical purposes; Diagnostic biomarker reagents for medical purposes; Immunostimulants; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Tumor suppressing agents; Pharmaceutical products for the prevention and treatment of cancer; Biological preparations for the treatment of cancer
Technical research in the field of pharmaceutical studies; Research and development of new products for others; Pharmaceutical product evaluation; Research and development services of new pharmaceutical products; Biological research; Research and development services in the field of immunology; Providing scientific research information in the field of pharmaceuticals; Conducting early evaluations in the field of new pharmaceuticals; Research and development services in the field of antibodies
